Charaka Hafida, Khalis Mohamed, Elfakir Samira, Chami Khazraji Youssef, Zidouh Ahmed, Abousselham Loubna, El Rhazi Karima, Lyoussi Badiaa, Nejjari Chakib
Department of Epidemiology, Faculty of Medicine and Pharmacy of Fez, Morocco. Email:
Asian Pac J Cancer Prev. 2016 Dec 1;17(12):5153-5157. doi: 10.22034/APJCP.2016.17.12.5153.
Objective: The benefits of screening and early detection of breast cancer, including reduced morbidity and mortality, have been well-reported in the literature. In 2011, a breast cancer screening program was launched in Meknes-Tafilalt region of Morocco. The aim of this study was to evaluate the early performance indicators of this program. Materials and Methods: This retrospective evaluative study was conducted between April 2012 and December 2014, in Meknes-Tafilalt region of Morocco. Several performance indicators of the breast cancer screening program were calculated: the compliance rate, the positivity rate, the referral rate, the cancer detection rate and the organizational indicators. Results: During 2012-2014, a total of 184,951 women participated in the breast cancer screening program. The compliance rate was 26%, the positive rate was 3.3%, the referral rate was 36.7%, and the cancer detection rate was 1.2 per 1,000 women. The median time between the date of clinical breast examination and the date of biopsy (or cyto-puncture) was 36 days. The median time between the date of positive mammography and the date of biopsy (or cyto-puncture) was 6 days. The median time between the date of clinical breast examination and the date of the first received treatment was 61 days. Conclusions: The program needs better monitoring, as well as implementation of quality assurance tools to improve performance in our country.
乳腺癌筛查及早期检测的益处，包括发病率和死亡率的降低，已在文献中得到充分报道。2011年，摩洛哥梅克内斯-塔菲拉勒特地区启动了一项乳腺癌筛查项目。本研究的目的是评估该项目的早期绩效指标。材料与方法：这项回顾性评估研究于2012年4月至2014年12月在摩洛哥梅克内斯-塔菲拉勒特地区进行。计算了乳腺癌筛查项目的几个绩效指标：依从率、阳性率、转诊率、癌症检出率和组织指标。结果：在2012年至2014年期间，共有184,951名女性参与了乳腺癌筛查项目。依从率为26%，阳性率为3.3%，转诊率为36.7%，癌症检出率为每1000名女性中有1.2例。临床乳腺检查日期与活检（或细胞穿刺）日期之间的中位时间为36天。乳腺X线摄影阳性日期与活检（或细胞穿刺）日期之间的中位时间为6天。临床乳腺检查日期与首次接受治疗日期之间的中位时间为61天。结论：该项目需要更好的监测，以及实施质量保证工具以提高我国的项目绩效。
